Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

January 20, 2016Open Access

Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Breast cancer chemotherapy is associated with long-term changes in immune parameters that should be considered during clinical management.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Verma et al. (Wed,) studied this question.

synapsesocial.com/papers/69d9a16d5e5bcb4e3b837466 https://doi.org/https://doi.org/10.1186/s13058-015-0669-x

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Alemtuzumab Treatment of Multiple Sclerosis2013 · 35 citations
2Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 20122014 · 29,059 citations
3The immune system and response to HER2-targeted treatment in breast cancer2014 · 295 citations
4Predictors of Health Care Use of Women with Breast Cancer: A Systematic Review2015 · 24 citations
5B‐cell diversity decreases in old age and is correlated with poor health status2008 · 446 citations

Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer | Synapse